Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus
- PMID: 15517626
Association of reduced CD4 T cell responses specific to varicella zoster virus with high incidence of herpes zoster in patients with systemic lupus erythematosus
Abstract
Objective: To examine whether the high incidence of herpes zoster in patients with systemic lupus erythematosus (SLE) is associated with the frequency of memory T cells specific to varicella zoster virus (VZV).
Methods: Whole blood samples from 47 subjects [24 patients with SLE, 11 with rheumatoid arthritis (RA) as a disease control, and 12 healthy negative controls] were stimulated with VZV antigen, stained for surface CD4 and CD8 and intracellularly stained for the cytokines interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin 4 (IL-4), and IL-10, followed by flow cytometry analyses. Correlations of VZV-specific T cell frequencies with the clinical status of patients were analyzed.
Results: Percentage of IFN-gamma-positive CD4 T cells was significantly lower in patients with SLE (0.043 +/- 0.009%) than in RA (0.102 +/- 0.019%) and healthy controls (0.126 +/- 0.025%) upon VZV stimulation. A similar pattern was seen in TNF-alpha-positive CD4 T cell responses. These low frequencies of VZV-specific CD4 T cells in patients with SLE were significantly related with disease activity (r = -0.435, p = 0.043).
Conclusion: These data suggest that the high incidence of herpes zoster in patients with SLE was related to the intrinsic defects in controlling VZV reactivation, and thus VZV-specific CD4 T cell frequency could be another practical risk factor of herpes zoster in patients with SLE.
Similar articles
-
Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.J Med Virol. 2012 Dec;84(12):2018-25. doi: 10.1002/jmv.23427. J Med Virol. 2012. PMID: 23080511
-
Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.Arthritis Rheumatol. 2014 Nov;66(11):3122-8. doi: 10.1002/art.38804. Arthritis Rheumatol. 2014. PMID: 25223407
-
Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.J Infect Dis. 2015 Feb 15;211(4):600-12. doi: 10.1093/infdis/jiu500. Epub 2014 Sep 1. J Infect Dis. 2015. PMID: 25180236
-
VZV T cell-mediated immunity.Curr Top Microbiol Immunol. 2010;342:341-57. doi: 10.1007/82_2010_31. Curr Top Microbiol Immunol. 2010. PMID: 20473790 Review.
-
Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine.Curr Opin Immunol. 2019 Aug;59:42-48. doi: 10.1016/j.coi.2019.02.009. Epub 2019 Apr 17. Curr Opin Immunol. 2019. PMID: 31003070 Review.
Cited by
-
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: a case report.BMC Infect Dis. 2020 Jul 23;20(1):538. doi: 10.1186/s12879-020-05254-6. BMC Infect Dis. 2020. PMID: 32703300 Free PMC article.
-
Distinctive Roles for Type I and Type II Interferons and Interferon Regulatory Factors in the Host Cell Defense against Varicella-Zoster Virus.J Virol. 2018 Oct 12;92(21):e01151-18. doi: 10.1128/JVI.01151-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30089701 Free PMC article.
-
VZV-specific T-cell levels in patients with rheumatic diseases are reduced and differentially influenced by antirheumatic drugs.Arthritis Res Ther. 2018 Nov 9;20(1):252. doi: 10.1186/s13075-018-1742-5. Arthritis Res Ther. 2018. PMID: 30413189 Free PMC article.
-
The case for Zostavax vaccination in systemic lupus erythematosus.Vaccine. 2013 Aug 12;31(36):3640-3. doi: 10.1016/j.vaccine.2013.05.085. Epub 2013 Jun 3. Vaccine. 2013. PMID: 23742992 Free PMC article. No abstract available.
-
Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.Clin Exp Immunol. 2008 Jun;152(3):522-31. doi: 10.1111/j.1365-2249.2008.03633.x. Epub 2008 Mar 20. Clin Exp Immunol. 2008. PMID: 18363743 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials